Carcinosarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Podcasts
• Clinical Trials

(VELA) Study of BLU-222 in Advanced Solid Tumors
Conditions:   ER+ Breast Cancer;   CCNE1 Amplification;   HER2-negative Breast Cancer;   Advanced Solid Tumor;   Ovarian Cancer;   Endometrial Cancer;   Gastric Cancer;   Esophageal Adenocarcinoma;   Carcinosarcoma Interventions:   Drug: BLU-222;   Drug: Carboplatin;   Drug: Ribociclib;   Drug: Fulvestrant Sponsor:   Blueprint Medicines Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2022 Category: Research Source Type: clinical trials